Call: Donor selection and protection
|Type of Fund||Action programme|
|Description of programme |
"Health Programme "
The EU is required by its founding treaty to ensure that human health is protected as part of all its policies, and to work with the EU countries to improve public health, prevent human illness and eliminate sources of danger to physical and mental health.
The 3rd Health Programme has 4 overarching objectives. It seeks to:
The third EU health programme is the main instrument the European Commission uses to implement the EU health strategy. It is implemented by means of annual work plans which set out priority areas and the criteria for funding actions under the programme. The total budget for the programme is € 449.4 million.
|Link||Link to Programme|
Donor selection and protection
|Description of call |
"Donor selection and protection"
The priority for this action is to increase the safety of donation and clinical application of tissues and cells and/or blood by optimising the procedures for donor selection and protection. While EU legislation defines the donor selection criteria in general terms, standardised procedures for gathering the necessary donor information are not developed at EU level. This is a high priority for these sectors because the success of transplantation, assisted reproduction and transfusion programmes relies heavily on achieving robust procedures for both the selection and protection of donors.
The objectives are:
This action should result in the development of common EU guidance on the selection and protection of donors and model questionnaires for use when interviewing prospective donors and/or donor families. The questions should be tested and validated to demonstrate that they are effective in terms of eliciting the information required for the application of exclusion criteria as defined in the EU legislation.
Description of the activities to be funded under a call for proposals
This action will bring together individuals and organisations from the tissues and cells and/or blood sectors with donor-facing expertise in those fields (e.g. physicians, key donation personnel from hospital to authority level) to address the following activities:
These approaches should include guidelines for screening donors, a proposal for a standardised donor and donor family questionnaire and proposals for short and long-term care and follow-up of living donors.
This action should build on previous EU-funded projects across the area of substances of human origin, in particular in organ donation/transplantation (e.g. DOMAINE, ELIPSY, ELPAT, and ACCORD). Involvement of relevant professional associations and competent authorities is strongly encouraged.
|Link||Link to Call|
|Thematic Focus||Research, Health, Innovation, Capacity Building, Administration|
|Funding area|| EU Member States |
Iceland / Ísland
Norway / Norge
|Origin of Applicant|| EU Member States |
Iceland / Ísland
Norway / Norge
|Eligible applicants||Education and Training Centres, Federal State / Region / City / Municipality / Local Authority, Research Institution, Lobby Group / Professional Association / Trade Union, International Organization, NGO / NPO, National Government, University, Public Services|
|Applicant details|| |
Grant applications are eligible if submitted by legal persons. More specifically, the applicants must be legally established organisations, public authorities, public sector bodies, in particular research and health institutions, universities and higher education establishments. The application shall state the legal status of the applicant.
|Project Partner Details|| |
Applicants participating in a project proposal have to be different legal entities (i.e. independent from each other) from at least 3 countries participating in the Health Programme. Proposals which involve fewer applicants will be rejected.
|Project duration max||36 months|
|Type of Funding||Grant|
|Financial details|| INDICATIVE AMOUNT Donor selection
and protection 550 000 €. |
Grants foreseen: one or more.
The EU grant is limited to a maximum co-funding rate of 60% of eligible costs. In case of exceptional utility up to 80% can be granted.
|Submission|| Before submitting a proposal: |